Literature DB >> 25043836

New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome.

Khine Win1, George M Rodgers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25043836     DOI: 10.1002/ajh.23797

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  18 in total

Review 1.  Renal involvement in antiphospholipid syndrome.

Authors:  Francisco Vileimar Andrade de Azevedo; Diego Germano Maia; Jozelio Freire de Carvalho; Carlos Ewerton Maia Rodrigues
Journal:  Rheumatol Int       Date:  2018-05-05       Impact factor: 2.631

2.  Direct oral anticoagulants in hypercoagulable states.

Authors:  Paul R Kunk; Jacqueline Brown; Melissa McShane; Surabhi Palkimas; B Gail Macik
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

Review 3.  The use of direct oral anticoagulants in inherited thrombophilia.

Authors:  Jessica W Skelley; C Whitney White; Angela R Thomason
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

Review 4.  Recurrent Thrombosis in Patients with Antiphospholipid Syndrome Receiving Newer Oral Anticoagulants: A Case Report and Review of Literature.

Authors:  Akanksha Joshi; Jason Hong; Chokkalingam Siva
Journal:  Clin Med Res       Date:  2017-06

Review 5.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Blood Rev       Date:  2017-07-30       Impact factor: 8.250

Review 6.  Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.

Authors:  Virginie Dufrost; Jessie Risse; Stéphane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

7.  Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.

Authors:  Flavio Signorelli; Felipe Nogueira; Vinicius Domingues; Henrique Ataide Mariz; Roger A Levy
Journal:  Clin Rheumatol       Date:  2015-07-30       Impact factor: 2.980

Review 8.  Emerging Therapies in Antiphospholipid Syndrome.

Authors:  Danieli Andrade; Maria Tektonidou
Journal:  Curr Rheumatol Rep       Date:  2016-04       Impact factor: 4.592

Review 9.  Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?

Authors:  Kimberly Janet Legault; Amaia Ugarte; Mark Andrew Crowther; Guillermo Ruiz-Irastorza
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

Review 10.  The antiphospholipid syndrome: still an enigma.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.